Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 5 , Pages 216-219 , September 2007

Echocardiography in Patients With Symptomatic Intracranial Stenosis

  • Scott E. Kasner, MD

      Affiliations

    • Department of Neurology, University of Pennsylvania Medical Center, Philadelphia
    • Corresponding Author InformationAddress correspondence to Scott E. Kasner, MD, Department of Neurology, University of Pennsylvania, 3 W Gates Bldg, 3400 Spruce St, Philadelphia, PA 19104.
  • ,
  • Michael J. Lynn, MS

      Affiliations

    • Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia
  • ,
  • Bryon P. Jackson, MD

      Affiliations

    • Department of Neurology, University of Pennsylvania Medical Center, Philadelphia
  • ,
  • Patrick M. Pullicino, MD

      Affiliations

    • Department of Neurology, University of Kent, Canterbury, United Kingdom.
  • ,
  • Marc I. Chimowitz, MB ChB

      Affiliations

    • Department of Neurology, Emory University, Atlanta, Georgia
  • ,
  • Warfarin Versus Aspirin for Symptomatic Intracranial Disease (WASID) Trial Investigators

Received 10 May 2007 ,Revised 20 June 2007 ,Accepted 3 July 2007.

References 

  1. Adams HP, Bendixen BH, Kappelle LJ, et al. TOAST Investigators Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke. 1993;24:35–41
  2. Petty GW, Brown RD, Whisnant JP, et al. Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke. 2000;31:1062–1068
  3. Kasner SE, Kimmel SE. Accuracy of initial stroke subtype diagnosis: A decision analysis. Cerebrovasc Dis. 2000;10:18–24
  4. McNamara RL, Lima JA, Whelton PK, et al. Echocardiographic identification of cardiovascular sources of emboli to guide clinical management of stroke: A cost-effectiveness analysis. Ann Intern Med. 1997;127:775–787
  5. Otto CM. Clinical indications for echocardiography (chapter 5). In:  Otto CM editors. Textbook of clinical echocardiography. Philadelphia: Elsevier Saunders; 2004;
  6. Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm; report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2004;62:1042–1050
  7. Macleod MR, Amarenco P, Davis SM, et al. Atheroma of the aortic arch: An important and poorly recognized factor in the etiology of stroke. Lancet Neurol. 2004;3:408–414
  8. Fujimoto S, Yasaka M, Otsubo R, et al. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke. 2004;35:1426–1429
  9. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. WASID Investigators Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316
  10. Kasner SE, Chimowitz MI, Lynn MJ, et al. WASID Investigators Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555–563
  11. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol. 1986;43:71–84

 Supported by a research grant (1R01 NS36643, Principal Investigator: Chimowitz MI) from the US Public Health Service, National Institute of Neurological Disorders and Stroke (NINDS). In addition, the following General Clinical Research centers, funded by the National Institutes of Health, provided local support for the evaluation of patients in the trial: Emory University (M01 RR00039), Case Western University, MetroHealth Medical Center (5M01 RR00080), San Francisco General Hospital (M01 RR00083-42), Johns Hopkins University School of Medicine (M01 RR000052), Indiana University School of Medicine (5M01 RR000750-32), Cedars–Sinai Hospital (M01 RR00425), and the University of Maryland (M01 RR165001).

 See appendix of reference 9 for list of WASID Investigators.

PII: S1052-3057(07)00102-4

doi: 10.1016/j.jstrokecerebrovasdis.2007.07.002

Journal of Stroke & Cerebrovascular Diseases
Volume 16, Issue 5 , Pages 216-219 , September 2007